article thumbnail

Innoviva enters agreement to acquire La Jolla Pharmaceutical Company

Pharmaceutical Technology

Innoviva has signed a definitive merger agreement for the acquisition of all of the outstanding shares of La Jolla Pharmaceutical Company for $6.23 The post Innoviva enters agreement to acquire La Jolla Pharmaceutical Company appeared first on Pharmaceutical Technology.

article thumbnail

Opinion: Needed: a new framework to make sure health companies play fair with patient data

STAT

As a health policy wonk and health economist who has worked in pharmaceutical companies in the United States, Latin America, and Europe, I’ve seen vast volumes of data generated, gathered, aggregated, analyzed, shared, and resold by health care companies and organizations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ECNP 2023: new esketamine NS safety data for depression

European Pharmaceutical Review

The Janssen Pharmaceutical Companies of Johnson & Johnson has revealed that according to new safety data, SPRAVATO ® (esketamine nasal spray [NS]) has demonstrated superior efficacy compared to quetiapine extended-release (Quetiapine XR) for treatment-resistant depression (TRD).

article thumbnail

PDA revises report on glass container manufacturing

European Pharmaceutical Review

According the PDA, the standardised quality criteria in TR 43 are intended as a guidance overview for container manufacturers and for incoming container acceptance inspection at pharmaceutical companies. The post PDA revises report on glass container manufacturing appeared first on European Pharmaceutical Review.

article thumbnail

Sanofi to sell Japanese manufacturing plant

European Pharmaceutical Review

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.

Packaging 104
article thumbnail

Healthcare’s COVID-19 backlog: how pharma can help

pharmaphorum

Pharmaceutical companies will undoubtedly place more emphasis on developing treatments that can be home administered and self-administered in the future, and payers and health technology assessors may well value those attributes more highly”. Pharmaceutical companies cannot address this challenge alone.

article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Where do most organizations start?